Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India
International Ophthalmology · 28.10.2026 · 46 (1)
DOI: 10.1007/s10792-026-04321-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Ophthalmology, online erschienen am 28.10.2026. Verfasst von Hridya Hareendran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ocular Oncology, Department of Surgical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalas…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Eye Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Ocular Oncology, Department of Surgical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalassery, Kerala, India.
- Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalassery, Kerala, India. menonabhilash18@gmail.com.
- Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalassery, Kerala, India.
ORCID-Profile: Abhilash Menon
Zitieren
APA
Hareendran, H., Menon, A., Shenoy, P. K., Rajan, N. D., Shoaib Nawaz, & Krishnan, M. P. A. (2026). Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04321-2
Vancouver
Hareendran H, Menon A, Shenoy PK, Rajan ND, Shoaib Nawaz, Krishnan MPA. Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04321-2
BibTeX
@article{Hareendran2026,
author = {Hareendran, Hridya and Menon, Abhilash and Shenoy, Praveen Kumar and Rajan, Nandini Devi and Shoaib Nawaz and Krishnan, M P Arun},
title = {Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India},
journal = {International Ophthalmology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10792-026-04321-2}
}
EUVIMED